Clinical Implication of Integrated PET-CT in the Patients With Pancreatic Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreatic Cancer
- Sponsor
- Asan Medical Center
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Staging of pancreatic cancer
- Last Updated
- 17 years ago
Overview
Brief Summary
In suspecting pancreatic cancer, dynamic phase pancreatic CT is the most effective tool in diagnosis and staging. In addition, magnetic resolution image, endoscopic ultrasonography, endoscopic retrograde pancreatography, angiography can be performed.
After introduction of functional image, PET has been suggested in the role of diagnosis and staging of pancreatic cancer. Furthermore, recently fused images of PET and CT were available.
In this study, the researchers evaluate the role of integrated PET-CT in patients with pancreatic cancer and analysis the cost-effectiveness of the integrated PET-CT.
Detailed Description
Compared to dynamic phase pancreatic CT, integrated PET-CT will be evaluated for sensitivity, specificity and accuracy of diagnosing and staging pancreatic cancer while the gold standard for pancratic cancer is operative specimen. If the operation can't be performed, EUS-FNA of the pancreatic mass or lymph node and additional imaging modality will be preferred to laparotomy.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pancreatic mass suspicious of pancreatic cancer
- •No comorbidity, expected life expectancy less than 6 months
- •Consent this study in letter
Exclusion Criteria
- •Refuse diagnostic and staging work-up
Outcomes
Primary Outcomes
Staging of pancreatic cancer
Time Frame: 6 months after study start
Secondary Outcomes
- Diagnosis of pancreatic cancer(6 months after study start)